This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Euronet's (EEFT) Unit Introduces Recurring Billing Solution
by Zacks Equity Research
Euronet's (EEFT) epay arm unveils a recurring billing solution in several countries to provide feasible subscription-based and buy-now-pay-later payments options.
MoneyGram (MGI) Announces Moves to Enhance Capital Position
by Zacks Equity Research
MoneyGram's (MGI) board unveils share buyback program and term loan repayment, which highlights its sound financial standing and prudent capital deployment efforts.
Best Momentum Stocks to Buy for October 29th
by Zacks Equity Research
BSVN, HLI, HAFC, and GOOGL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 29, 2021.
Houlihan Lokey (HLI) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Houlihan Lokey (HLI) delivered earnings and revenue surprises of 43.70% and 44.03%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Best Momentum Stocks to Buy for October 22nd
by Zacks Equity Research
HLI, OVV, and CACC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 22, 2021.
Houlihan Lokey (HLI) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Houlihan Lokey (HLI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synchrony Financial's (SYF) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Synchrony Financial's (SYF) third-quarter results benefit on the back of improved purchase volume and reduced expenses.
Zacks.com featured highlights include: Regeneron Pharm, Evercore, Houlihan Lokey and DICK'S Sporting Goods
by Zacks Equity Research
Zacks.com featured highlights include: Regeneron Pharm, Evercore, Houlihan Lokey and DICK'S Sporting Goods
4 Top-Ranked Stocks to Invest in for Solid Earnings Growth
by Tirthankar Chakraborty
Regeneron Pharmaceuticals (REGN), Evercore (EVR), Houlihan Lokey (HLI) & DICK'S Sporting Goods (DKS) currently have striking earnings growth and positive estimate revisions, which make them must-buys.
Is a Beat in Store for Discover Financial (DFS) in Q3 Earnings?
by Zacks Equity Research
Discover Financial's (DFS) third-quarter results are likely to reflect strong sales volume and new account growth, partly offset by elevated costs.
AmEx (AXP) Adds Benefits to Serve Platinum Card Members
by Zacks Equity Research
American Express (AXP) includes benefits from Walmart+ and SoulCycle in its U.S. Consumer Platinum Card. Members will benefit from the same while conducting daily and lifestyle purchases.
Houlihan Lokey (HLI) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Houlihan Lokey (HLI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Should You Hold Virtu Financial (VIRT) in Your Portfolio?
by Zacks Equity Research
Riding high on solid segmental performances and capital position, Virtu Financial (VIRT) holds prospects to reap benefits for investors.
Why Should You Hold Owl Rock Capital (ORCC) in Your Portfolio?
by Zacks Equity Research
An impressive portfolio and a healthy revenue stream make Owl Rock Capital (ORCC) an attractive stock.
Houlihan Lokey (HLI) Up on Acquisition of 90% Shares of GCA
by Zacks Equity Research
After successfully completing a tender offer process, Houlihan Lokey (HLI) acquires 90% of GCA's common stock.
Euronet's (EEFT) REN Payments Platform to Aid Marker Trax
by Zacks Equity Research
Euronet's (EEFT) REN platform forms a relationship with Marker Trax to serve physical casinos, virtual casinos and the sports-betting operators.
Euronet's (EEFT) Arm Forms Alliance With Paytm Payments Bank
by Zacks Equity Research
Euronet's (EEFT) Ria Money ties up with Paytm to establish its dominance in the Indian remittance market.
Euronet's (EEFT) Ria Money, Nobel Financial Form Partnership
by Zacks Equity Research
Euronet's (EEFT) arm Ria Money strengthens its position and boosts portfolio by establishing its relationship with Nobel Financial.
PRA Group (PRAA) Declares Pricing of Senior Notes Offering
by Zacks Equity Research
To boost financial flexibility, PRAA Group (PRAA) prices senior notes to procure funds and pay back its outstanding revolving borrowings under the North American Credit Agreement.
Why Should You Hold PRA Group (PRAA) in Your Portfolio?
by Zacks Equity Research
Riding high on inorganic growth strategies and cash collections, PRA Group (PRAA) holds enough potential to reap benefits for investors.
Euronet (EEFT) Arm Integrates PayPal QR Code to Aid Retailers
by Zacks Equity Research
Euronet's (EEFT) epay unit enhances its portfolio by providing the PayPal QR Code for the brick-and-mortar retailers.
Why Should You Hold Owl Rock Capital (ORCC) in Your Portfolio?
by Zacks Equity Research
Riding high on a solid portfolio and rising revenues, Owl Rock Capital (ORCC) holds potential to reap benefits for investors.
Here's Why You Should Stay Away From Virtu Financial (VIRT)
by Zacks Equity Research
Stable market conditions and high expenses make Virtu Financial (VIRT) an unattractive stock right now.
Houlihan Lokey (HLI) Tops Q1 Earnings Estimates
by Zacks Equity Research
Houlihan Lokey (HLI) delivered earnings and revenue surprises of 2.59% and -3.26%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Houlihan Lokey (HLI) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Houlihan Lokey (HLI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.